Apparatus New Findings Confirm: Excellent Data On This Bipotent Antibody Drug Against Ovarian Cancer! Aug 20, 2024 Aug 20, 2024 The results of a new study show that Ubamatamab, a bispecific antibody drug, has shown excellent results and a good safety profile in patients with ovarian cancer.
